In the recent years, a translation elongation factor of the eukaryotic elongation factor 1 alpha (EEF1A) family, namely eukaryotic elongation factor 1 alpha 2 (EEF1A2) has attracted much attention due to multiple studies highlighting its role as an oncogene, across different cancers [5–10]. This evidence concerns the gene EEF1A2 and cancer.